The deal will see Germany's Boehringer pay Sanofi €4.7 billion as part of the deal, with Merial valued at €11.4 billion and its global consumer health (CHC) division – except its business in ...

Sanofi will now have a consumer healthcare (CHC) business worth around €4.9 billion based upon 2015 global sales, although BI has kept hold of its consumer health operations in China.

Sanofi’s SNY stock has declined 10.2% in the ... The EPS estimate has declined to exclude costs related to its Consumer Healthcare (CHC) unit, which the company plans to separate through the ...

The Food and Drug Administration has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility in Massachusetts where the company makes ...

Sanofi (NASDAQ:SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, its consumer healthcare business, to private equity firm CD&R. The terms of ...

Sanofi Consumer Healthcare India has reported 1% rise in net profit to Rs 46.35 crore on a 6.8% increase in net sales to Rs 170.70 crore in Q3 FY25 as compared with Q3 FY24.

Aspercreme, a topical pain relief cream brand, increased sales, purchase intent, and reach by capitalising on the TikTok trend of #HeelHacks. Aspercreme has been a trusted brand in the topical pain ...

Sanofi has bought back a €3bn ($3.1bn) stake held by cosmetics giant L'Oréal, the first of multiple share buybacks the French drugmaker has planned for 2025. L'Oréal was selling 29,556,650 ...

Little thought was given to media, and if it was, the advice from the environmentalist camp was to just cut back on advertising: no media, no carbon. Simple. Prasad Shridhar Ghag, global head of media ...

Sanofi SNY reported fourth-quarter 2024 adjusted earnings of 70 cents per American depositary share, which missed the Zacks Consensus Estimate of 71 cents per share. Earnings of €1.31 per share ...